Solving the Problem of Insolubility: Part III
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Biopharma’s Survival Moment
March 2, 2026
Why the next decade will be defined by operational reinvention, not just scientific breakthroughs
5 min read
MHRA Approval for First UK-made mRNA Vaccine
February 27, 2026
Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1
1 min read
Closing the Genomic Gap in Rare Disease
February 27, 2026
Ahead of Rare Disease Day, leaders from iHope and PacBio explore how technology, collaboration, and policy reform can bring accurate genomic diagnosis
6 min read
Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery
February 25, 2026
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
1 min read
Solving the Problem of Insolubility: Part II
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
Building an Integrated Discovery Engine
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
A Practical Approach to Early-Phase CMC
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
A Simpler, Smarter CHO Strategy for High-Quality Bispecifics
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.